Incyte

Incyte Corporation is a global biopharmaceutical company based in Wilmington, Delaware. Founded in 1991, the company focuses on discovering, developing, and commercializing proprietary therapeutics, primarily in oncology, inflammation, and autoimmunity. Incyte has expanded its operations and research facilities across North America, Europe, and Asia, emphasizing its commitment to addressing serious unmet medical needs. The company develops and manufactures prescription biopharmaceutical medications, with a strong portfolio of approved products and ongoing clinical trials. Incyte collaborates with other organizations, including Jiangsu Hengrui Medicine and MorphoSys, to enhance its offerings in innovative cancer therapies and treatments for inflammatory and autoimmune conditions. With over 2,500 employees, Incyte fosters a collaborative and innovative work environment, aiming to deliver effective therapies to patients worldwide.

Pharmaceuticals Wilmington, United States Founded 1991 ~1,915 employees NASDAQ: INCY

Work at Incyte in HR or recruiting? Claim this page

Employees
1,915
+2% in 3 months
Revenue / employee
$2.3M
Revenue ~$4.4B
Stock
INCY
NASDAQ
12-month attrition
6.4%
Tech: 9.9%
H1B filings, FY2026
20
Sponsors visas

Headcount trend

Incyte went from 1,706 employees in Jul 2023 to 1,915 in Jun 2025. Last 6 months: 153 people joined, 26 left.

Org structure

Headcount by department

Other1,455
Operations188
Sales107
Engineering70
Marketing37
Finance33
HR14
Success7

Executive compensation

Salaries at Incyte

All salaries

12 salary profiles in the US

Pay by level, gender and ethnicity

H-1B sponsorship

H-1B Sponsorship Moderate
H-1B Filings by Department
Engineering70
Operations8
Executive7
IT2
Consulting1

The department split adds up all the years listed above. FY2026 alone: 20 filings.

Peer reviews

Worked with someone at Incyte?

Anonymous peer reviews on OffTheRecord

Read or write a review

Similar companies

Incyte FAQ

How many employees does Incyte have?

Incyte has about 1,915 employees, up 2% over the last 3 months (as of Jun 2025).

Does Incyte sponsor H1B visas?

Yes. Incyte filed 20 H1B (LCA) applications in FY2026, according to the latest U.S. Department of Labor disclosures. Most of them were for Engineering roles.

What is Incyte's revenue per employee?

Incyte makes about $2.3M in revenue per employee, based on $4.41B annual revenue and 1,915 employees.

How much does Incyte pay?

6figr has 12 salary profiles for Incyte in the US, with pay broken down by role, level, gender and ethnicity on the Incyte salaries page. See Incyte salaries

Is Incyte a public company?

Yes. Incyte is publicly traded under the ticker INCY on NASDAQ.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles. Updated 11 Oct 2026.